Blue Cohosh
BerberidaceaeCaulophyllum thalictroides
Also known as: Papoose Root, Squaw Root, Blue Ginseng
clinical_notes Clinical Summary
Blue Cohosh (Caulophyllum thalictroides) is a historically significant Native American and Eclectic medicine herb for female reproductive conditions, but it carries serious documented safety concerns that severely limit its therapeutic application.
N-methylcytisine and caulosaponin produce coronary vasoconstriction and nicotine-like cardiovascular effects; three clinical case reports link perinatal use to neonatal myocardial infarction, CHF, stroke, and multi-organ failure.
It is absolutely contraindicated in pregnancy and lactation.
In non-pregnant women, it may be cautiously used under professional supervision for dysmenorrhoea from poor uterine tone, but CYP inhibition and cardiovascular monitoring are essential.
Its risk profile makes it one of the highest-risk herbs in clinical herbal practice.
Pregnancy Safety
ABSOLUTELY CONTRAINDICATED throughout pregnancy. Clinical case reports of neonatal cardiac toxicity (MI, CHF, stroke) from perinatal use. In vitro teratogenic, embryotoxic, and oxytocic evidence. Do not use under any circumstances without direct specialist supervision and informed consent.
Lactation Safety
Contraindicated during breastfeeding. Can cause severe GI and cardiovascular toxicity; alkaloid transfer to breast milk possible. All sources strongly advise against use.
warning Contraindications
- Pregnancy (first and second trimester) (contraindicated)Clinically Proven
- Near-term labour use (without medical supervision) (contraindicated)Clinically Proven
- Cardiovascular disease (angina, hypertension) (avoid)Clinically Proven
- Lactation (avoid)Theoretical
vital_signs Clinical Profile
Primary Indications
- check_circle dysmenorrhoea (poor uterine tone)
- check_circle amenorrhoea
- check_circle irregular menstruation
- check_circle pelvic inflammatory disease
- check_circle endometriosis
- check_circle uterine atony
- check_circle rheumatic conditions
- check_circle muscle spasm
Therapeutic Actions
System Affinities
- check_circle female reproductive
- check_circle musculoskeletal
- check_circle nervous system
labs Active Constituents
triterpenoid saponins
alkaloids
resins
taspine
leontin
history_edu Traditional Use
No TCM data available for this herb yet.
Traditional Uses Across Healing Systems
While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.
Multiple Eastern Woodland Native American tribes (Menomini, Ojibwe, Potawatomi, Meskwaki) used blue cohosh for menstrual cramps, to suppress excessive menstruation, and to stimulate uterine contractions in labour. Also used as a sedative and for rheumatism.
The name cohosh comes from the Algonquin word for rough, referring to the rhizome texture.
19th century Eclectic medicine used blue cohosh as a uterine tonic during last 4-6 weeks of pregnancy to prepare for labour; emmenagogue for irregular periods and dysmenorrhoea due to poor uterine tone; antispasmodic for pelvic inflammatory conditions.
Eclectic physicians Finley Ellingwood and John William Fyfe wrote extensively on its use. Modern herbal use sharply curtailed due to neonatal toxicity case reports.
spa Parts Used
No parts information available.
shield Safety
Contraindications — Evidence Basis
Pregnancy (first and second trimester)
Absolutely contraindicated. Case reports of perinatal stroke, acute myocardial infarction, profound congestive heart failure, and severe multi-organ hypoxic injury in neonates of mothers who used blue cohosh near delivery. Teratogenic in vitro evidence. N-methylcytisine has nicotine-like cardiovascular effects on the developing fetus.
Near-term labour use (without medical supervision)
Three clinical case reports link maternal use at delivery to neonatal cardiac events (MI, CHF, stroke). Must not be used as self-administered labour-inducing agent. Only under strict medical supervision if at all.
Cardiovascular disease (angina, hypertension)
Caulosaponin constricts coronary vessels and may reduce cardiac oxygen supply. N-methylcytisine has nicotine-like cardiovascular effects. Contraindicated in coronary artery disease and hypertension.
Lactation
No safety data in lactation. Potential for alkaloid transfer to breast milk. Most sources strongly recommend against use during breastfeeding.
Monitoring Parameters
Monitor during use, especially with prolonged or high-dose therapy.
Blood pressure and heart rate
Before and during any therapeutic use in non-pregnant adultsCaulosaponin constricts coronary vessels; N-methylcytisine has nicotine-like cardiovascular effects including hypertension and tachycardia
flagThreshold: BP > 140/90 or HR > 100: discontinue immediately
Toxicity
Toxicity reported at therapeutic doses in vulnerable populations (near-term pregnancy). General adult use also associated with GI upset, chest pain, and elevated blood pressure.
In adults: diarrhoea, stomach cramps, chest pain, elevated blood pressure, tachycardia. In neonates (maternal use): MI, CHF, perinatal stroke, multi-organ failure.
Discontinue immediately. Neonatal toxicity: emergency neonatal cardiac support, intensive care. Adult toxicity: symptomatic supportive care; ECG monitoring for cardiac effects.
Adverse Effects
CYP Metabolism
Alkaloids (saponins, magnoflorine) shown to inhibit CYP3A4, CYP1A2, and CYP2D6 in vitro. Clinical significance in human dosing not established but potential for drug interactions with CYP substrates exists.
swap_horiz Interactions
Oxytocin (Syntocinon, Pitocin)
Class: Uterotonic / Oxytocic Agent
Caulophyllum thalictroides contains caulosaponin and triterpene saponins that act directly on uterine smooth muscle to produce oxytocic responses. Alkaloids including N-methylcytisine further stimulate uterine contractility through nicotinic receptor mechanisms. Combined with exogenous oxytocin, blue cohosh produces dangerous additive uterotonic effects, potentially causing uterine hyperstimulation, fetal distress, and catastrophic obstetric complications.
Blue cohosh is absolutely contraindicated with oxytocin or any uterotonic agent. Case reports document neonatal myocardial infarction, congestive heart failure, and perinatal stroke in infants exposed to maternal blue cohosh use near term. Women in labour must not receive both agents. Midwives must be specifically trained regarding this interaction.
Antihypertensives (ACE Inhibitors, Calcium Channel Blockers, Beta-blockers)
Class: Antihypertensive
Caulosaponin in blue cohosh constricts coronary vessels and raises blood pressure through vasoconstriction. This vasoconstrictive activity may antagonise the therapeutic effect of antihypertensive medications including ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers, leading to inadequate blood pressure control.
Patients with hypertension or cardiovascular disease should not use blue cohosh. Monitor blood pressure closely if exposure occurs. Alert cardiovascular specialists to any blue cohosh use in patients with hypertension, coronary artery disease, or those on antihypertensive therapy.
Nicotine Replacement Therapy / Nicotinic Drugs (Varenicline)
Class: Smoking Cessation / Nicotinic Receptor Agonist
Blue cohosh contains N-methylcytisine, a quinolizidine alkaloid with nicotine-like agonist activity at nicotinic acetylcholine receptors. Combined use with nicotine replacement therapy (patches, gum, inhalers) or nicotinic receptor drugs like varenicline produces additive nicotinic receptor stimulation, potentially causing nausea, vomiting, tachycardia, hypertension, and nicotine toxicity symptoms.
Patients undergoing smoking cessation with nicotine replacement or varenicline should not concurrently use blue cohosh. Inform prescribers of any blue cohosh use. Monitor for nicotinic toxicity signs including tachycardia, hypertension, nausea, and confusion.
CYP3A4 Substrates (Cyclosporine, Midazolam, Simvastatin, Estradiol)
Class: CYP3A4 Substrates (Multiple Drug Classes)
Alkaloids from Caulophyllum thalictroides (magnoflorine, saponins, baptifoline) have demonstrated in vitro CYP3A4 inhibitory activity. CYP3A4 inhibition reduces the metabolism of a wide range of drugs including immunosuppressants (cyclosporine, tacrolimus), benzodiazepines (midazolam), statins (simvastatin, atorvastatin), and hormonal drugs, potentially raising plasma levels and increasing toxicity risk.
Patients on narrow therapeutic index CYP3A4 substrates (particularly cyclosporine, tacrolimus, or midazolam) should be warned against blue cohosh use. In vitro data suggests clinically relevant inhibition potential. Monitor therapeutic drug levels and watch for signs of drug accumulation.
Cardiac Medications (Digoxin, Antiarrhythmics)
Class: Cardiovascular
Blue cohosh alkaloids and glycosides produce direct vasoconstrictive effects on coronary vessels, reducing myocardial oxygen supply. Caulosaponin has been documented to cause myocardial ischaemia in neonates exposed in utero. Combined with cardiac medications that affect myocardial contractility or conduction (digoxin, class I/III antiarrhythmics), the risk of arrhythmia and myocardial infarction is substantially increased.
Blue cohosh is contraindicated in patients with any cardiac condition or on cardiac medications. Report any case of blue cohosh use in patients with ischaemic heart disease, arrhythmia, or heart failure to their cardiologist immediately. Case reports of neonatal myocardial infarction from maternal use underscore the severity of this herbs cardiac effects.
hub Combinations
Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.
Possible Substitutes
1Wild Yam
Traditional UseWild Yam is a safer alternative to Blue Cohosh for uterine antispasmodic and anti-inflammatory effects in menstrual disorders; preferred during pregnancy where Blue Cohosh is contraindicated.
Wild Yam provides comparable antispasmodic properties with a significantly better safety profile.
Synergistic Combinations
1Cramp Bark
Traditional UseUterine antispasmodic combination for non-pregnant dysmenorrhoea; Cramp Bark relaxes smooth muscle while Blue Cohosh tones uterine tissue. Used by Eclectic physicians for spasmodic dysmenorrhoea.
Traditional Eclectic combination for dysmenorrhoea in non-pregnant women. Not for use in pregnancy.
Traditional Pairings
1Black Cohosh
Limited EvidenceHistorical Eclectic combination as partus preparators (labour preparation). Black Cohosh addresses hormonal and neurological aspects while Blue Cohosh strengthens uterine tone. NOW GENERALLY AVOIDED due to documented neonatal cardiac toxicity when used near term.
Case reports document severe neonatal toxicity with this combination near delivery. Historically used by midwives but now discouraged by most practitioners.
science Studies
Anti-Inflammatory Effect of Triterpene Saponins Isolated from Blue Cohosh (Caulophyllum thalictroides)
In VitroThis in vitro study characterized the anti-inflammatory properties of triterpene saponins and crude extracts from Caulophyllum thalictroides (blue cohosh) in LPS-activated microglia (BV2 cells) and adrenal gland tissue from mice. Blue cohosh constituents suppressed LPS-induced iNOS expression, TNF-α, IL-1β, and IL-6 in a concentration-dependent manner. COX-2 expression in adrenal glands of LPS-injected mice was also significantly suppressed by crude saponin (200 mg/kg). These results suggest that blue cohosh saponins act as anti-inflammatory agents through multiple pathways, potentially explaining the traditional use of C. thalictroides as an anti-inflammatory and antipyretic remedy for rheumatic pain and menopausal symptoms.
Teratogenic effects of blue cohosh (Caulophyllum thalictroides) in Japanese medaka (Oryzias latipes) are probably mediated through GATA2/EDN1 signaling pathway
In VivoThis toxicological study used Japanese medaka fish embryos to investigate the developmental toxicity and mechanism of Caulophyllum thalictroides methanolic root extract. Blue cohosh extract produced dose- and stage-specific morphological abnormalities including craniofacial and cardiovascular defects in medaka embryos. Mechanistic analysis identified GATA2/EDN1 (endothelin) signaling pathway disruption as the probable mechanism underlying cardiovascular malformations, supporting clinical case reports of neonatal cardiovascular toxicity when blue cohosh is used in labor. The study confirmed teratogenic potential of blue cohosh at relevant concentrations, raising serious concerns about its safety profile during pregnancy and near birth.
medication Dosing
No dosing information available.
Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.
© 2026 Evara Health. All rights reserved.